Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 14.01 USD -0.85% Market Closed
Market Cap: 637m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-15.1
Current
-6.2
Median
5.9
Industry
Lower than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-15.1
=
Enterprise Value
555.4m USD
/
Operating Cash Flow
-36.8m USD
All Countries
Close
 
US
Capricor Therapeutics Inc
NASDAQ:CAPR
Average EV/OCF: 22.1
Negative Multiple: -15.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 741.6
US
Abbvie Inc
NYSE:ABBV
22.4
US
Amgen Inc
NASDAQ:AMGN
26.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.7
AU
CSL Ltd
ASX:CSL
34.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.5
NL
argenx SE
XBRU:ARGX
Negative Multiple: -133

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More